These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 11519886)

  • 1. IGF-I does not improve fat malabsorption in cirrhotic rats.
    Pérez R; Castilla-Cortázar I; Núñez M; Prado A; Mirpuri E; García M; González Barón S; Picardi A
    J Physiol Biochem; 2001 Mar; 57(1):59-60. PubMed ID: 11519886
    [No Abstract]   [Full Text] [Related]  

  • 2. IGF-I does not improve fat malabsorption in cirrhotic rats.
    Pérez R; Castilla-Cortázar I; Núñez M; Prado A; Mirpuri E; García M; González Barón S; Picardi A
    J Physiol Biochem; 2001 Mar; 57(2):59-60. PubMed ID: 11579998
    [No Abstract]   [Full Text] [Related]  

  • 3. Altered intestinal transport of amino acids in cirrhotic rats: the effect of insulin-like growth factor-I.
    Pascual M; Castilla-Cortazar I; Urdaneta E; Quiroga J; Garcia M; Picardi A; Prieto J
    Am J Physiol Gastrointest Liver Physiol; 2000 Aug; 279(2):G319-24. PubMed ID: 10915640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IGF-1 decreases portal vein endotoxin via regulating intestinal tight junctions and plays a role in attenuating portal hypertension of cirrhotic rats.
    Zhao TY; Su LP; Ma CY; Zhai XH; Duan ZJ; Zhu Y; Zhao G; Li CY; Wang LX; Yang D
    BMC Gastroenterol; 2015 Jul; 15():77. PubMed ID: 26152281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of insulin-like growth factor I on in vivo intestinal absorption of D-galactose in cirrhotic rats.
    Castilla-Cortázar I; Picardi A; Tosar A; Ainzúa J; Urdaneta E; García M; Pascual M; Quiroga J; Prieto J
    Am J Physiol; 1999 Jan; 276(1):G37-42. PubMed ID: 9886976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low doses of insulin-like growth factor-I improve nitrogen retention and food efficiency in rats with early cirrhosis.
    Picardi A; de Oliveira AC; Muguerza B; Tosar A; Quiroga J; Castilla-Cortázar I; Santidrián S; Prieto J
    J Hepatol; 1997 Jan; 26(1):191-202. PubMed ID: 9148011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-like growth factor-I reverts testicular atrophy in rats with advanced cirrhosis.
    Castilla-Cortazar I; Garcia M; Quiroga J; Diez N; Diez-Caballero F; Calvo A; Diaz M; Prieto J
    Hepatology; 2000 Mar; 31(3):592-600. PubMed ID: 10706548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factor I improves intestinal barrier function in cirrhotic rats.
    Lorenzo-Zúñiga V; Rodríguez-Ortigosa CM; Bartolí R; Martínez-Chantar ML; Martínez-Peralta L; Pardo A; Ojanguren I; Quiroga J; Planas R; Prieto J
    Gut; 2006 Sep; 55(9):1306-12. PubMed ID: 16434425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired intestinal sugar transport in cirrhotic rats: correction by low doses of insulin-like growth factor I.
    Castilla-Cortazar I; Prieto J; Urdaneta E; Pascual M; Nuñez M; Zudaire E; Garcia M; Quiroga J; Santidrian S
    Gastroenterology; 1997 Oct; 113(4):1180-7. PubMed ID: 9322513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steatorrhoea in cirrhosis: effect of ursodeoxycholic acid administration.
    Salvioli G; Carati L; Lugli R
    J Int Med Res; 1990; 18(4):289-97. PubMed ID: 2227076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antioxidant effects of insulin-like growth factor-I (IGF-I) in rats with advanced liver cirrhosis.
    García-Fernández M; Castilla-Cortázar I; Díaz-Sanchez M; Navarro I; Puche JE; Castilla A; Casares AD; Clavijo E; González-Barón S
    BMC Gastroenterol; 2005 Mar; 5():7. PubMed ID: 15745444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver transduction with a simian virus 40 vector encoding insulin-like growth factor I reduces hepatic damage and the development of liver cirrhosis.
    Vera M; Sobrevals L; Zaratiegui M; Martinez L; Palencia B; Rodríguez CM; Prieto J; Fortes P
    Gene Ther; 2007 Feb; 14(3):203-10. PubMed ID: 17024107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced actions of insulin-like growth factor-I and interferon-alpha co-administration in experimental cirrhosis.
    Tutau F; Rodríguez-Ortigosa C; Puche JE; Juanarena N; Monreal I; García Fernández M; Clavijo E; Castilla A; Castilla-Cortázar I
    Liver Int; 2009 Jan; 29(1):37-46. PubMed ID: 18544128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fat absorption and malabsorption.
    Glickman RM
    Clin Gastroenterol; 1983 May; 12(2):323-34. PubMed ID: 6347460
    [No Abstract]   [Full Text] [Related]  

  • 15. [Absorption test of fat].
    Nakamura T
    Nihon Rinsho; 1997 Apr; 55 Suppl 2():111-2. PubMed ID: 9172482
    [No Abstract]   [Full Text] [Related]  

  • 16. Insulin-like growth factor-I, liver function, and hypogonadism in rats with experimentally induced cirrhosis.
    Castilla-Cortazar I; Quiroga J; Prieto J
    Hepatology; 2000 Jun; 31(6):1379. PubMed ID: 10866524
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of cirrhotic rats with epidermal growth factor and insulin accelerates liver DNA synthesis after partial hepatectomy.
    Hashimoto M; Kothary PC; Eckhauser FE; Raper SE
    J Gastroenterol Hepatol; 1998 Dec; 13(12):1259-65. PubMed ID: 9918436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the ileum in fat absorption.
    Wollaeger EE
    Mayo Clin Proc; 1973 Dec; 48(12):836-43. PubMed ID: 4594157
    [No Abstract]   [Full Text] [Related]  

  • 19. Insulin growth factor I and hypogonadism in cirrhosis.
    Mezey E
    Hepatology; 2000 Mar; 31(3):783-4. PubMed ID: 10706573
    [No Abstract]   [Full Text] [Related]  

  • 20. Fat absorption and metabolism in bile duct ligated rats.
    De Vriese SR; Savelii JL; Poisson JP; Narce M; Kerremans I; Lefebvre R; Dhooge WS; De Greyt W; Christophe AB
    Ann Nutr Metab; 2001; 45(5):209-16. PubMed ID: 11585978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.